186 related articles for article (PubMed ID: 23465863)
1. Chronic myopathy due to immunoglobulin light chain amyloidosis.
Manoli I; Kwan JY; Wang Q; Rushing EJ; Tsokos M; Arai AE; Burch WM; Dispenzieri A; McPherron AC; Gahl WA
Mol Genet Metab; 2013 Apr; 108(4):249-54. PubMed ID: 23465863
[TBL] [Abstract][Full Text] [Related]
2. Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome.
Muchtar E; Derudas D; Mauermann M; Liewluck T; Dispenzieri A; Kumar SK; Dingli D; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Leung N; Chakraborty R; Gonsalves W; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Kyle RA; Rajkumar SV; Gertz MA
Mayo Clin Proc; 2016 Oct; 91(10):1354-1361. PubMed ID: 27712634
[TBL] [Abstract][Full Text] [Related]
3. Systemic immunoglobulin light-chain amyloidosis.
Comenzo RL
Clin Lymphoma Myeloma; 2006 Nov; 7(3):182-5. PubMed ID: 17229332
[TBL] [Abstract][Full Text] [Related]
4. [Non hypertrophic amyloid myopathy with muscular inflammation in plasma cell dyscrasia].
Pouget J; Pellissier JF; Azulay JP; Vallat JM; Visy JM; Serratrice G
Rev Neurol (Paris); 1992; 148(3):200-6. PubMed ID: 1604134
[TBL] [Abstract][Full Text] [Related]
5. Lambda light chain deposition disease presenting as an amyloid-like arthropathy.
Rivest C; Turgeon PP; Senécal JL
J Rheumatol; 1993 May; 20(5):880-4. PubMed ID: 8336318
[TBL] [Abstract][Full Text] [Related]
6. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
[TBL] [Abstract][Full Text] [Related]
7. Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.
Draghici M; Jercan A; Badelita SN; Irimia RM; Bastian AE; Dobrea C; Popescu M; Coriu D
Medicine (Baltimore); 2021 Dec; 100(51):e28267. PubMed ID: 34941106
[TBL] [Abstract][Full Text] [Related]
8. Expanding the spectrum of monoclonal light chain deposition disease in muscle.
Ostrow LW; Corse AM; Morrison BM; Huff CA; Carrino JA; Hoke A; Mammen AL
Muscle Nerve; 2012 May; 45(5):755-61. PubMed ID: 22499107
[TBL] [Abstract][Full Text] [Related]
9. Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy.
Chitimus DM; Berling E; Garderet L; Venturelli N; Malfatti E; Authier FJ; Nicolas G; Laforêt P; Lefeuvre C
Eur J Neurol; 2023 Mar; 30(3):745-748. PubMed ID: 36403110
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin light chain amyloidosis and the kidney.
Gertz MA; Lacy MQ; Dispenzieri A
Kidney Int; 2002 Jan; 61(1):1-9. PubMed ID: 11786079
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the management of AL Amyloidosis.
Kastritis E; Dimopoulos MA
Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
13. Marked and rapid regression of hepatic amyloid deposition in a patient with systemic light chain (AL) amyloidosis after high-dose melphalan therapy with stem cell transplantation.
Katoh N; Matsushima A; Kurozumi M; Matsuda M; Ikeda S
Intern Med; 2014; 53(17):1991-5. PubMed ID: 25175136
[TBL] [Abstract][Full Text] [Related]
14. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
[TBL] [Abstract][Full Text] [Related]
16. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
18. [Amyloid light chain amyloidosis].
Suzuki K; Shimizu T
Brain Nerve; 2014 Jul; 66(7):795-809. PubMed ID: 24998824
[TBL] [Abstract][Full Text] [Related]
19. Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftment.
Cowan AJ; Seldin DC; Skinner M; Quillen K; Doros G; Tan J; O'Hara C; Finn KT; Sanchorawala V
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1935-8. PubMed ID: 22842332
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary light chain deposition disease: report of five cases and review of the literature.
Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
